[{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 35 40  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9125   -0.3917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.1792    0.8375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9042    0.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2042   -0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4750    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 10  1  0  0  0  0\r\n 15 12  1  0  0  0  0\r\n 16 14  2  0  0  0  0\r\n 17 23  2  0  0  0  0\r\n 18 17  1  0  0  0  0\r\n 19 14  1  0  0  0  0\r\n 20 15  2  0  0  0  0\r\n 21 28  1  0  0  0  0\r\n 22 29  2  0  0  0  0\r\n 23 27  1  0  0  0  0\r\n 24 22  1  0  0  0  0\r\n 25  9  1  0  0  0  0\r\n 26 19  1  0  0  0  0\r\n 27 26  1  0  0  0  0\r\n 28 18  2  0  0  0  0\r\n 29 18  1  0  0  0  0\r\n 30 20  1  0  0  0  0\r\n 31 32  2  0  0  0  0\r\n 32 33  1  0  0  0  0\r\n 33 27  2  0  0  0  0\r\n 34 25  1  0  0  0  0\r\n 35 30  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 16 20  1  0  0  0  0\r\n 31 17  1  0  0  0  0\r\n 24 21  2  0  0  0  0\r\nM  END","cdbregno":"1","id":"ex 1(page 78)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"1.06","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"1.060000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 39 44  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n   10.6292   -0.8000    0.0000 C   0  0  3  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9125   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2042   -0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   11.2875   -1.1667    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0\r\n   10.7792   -1.6500    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0\r\n   11.4375   -0.4875    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9042    0.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4750    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.1792    0.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 16  1  0  0  0  0\r\n 15 10  1  0  0  0  0\r\n 16 19  1  0  0  0  0\r\n 17 12  1  0  0  0  0\r\n 18 15  2  0  0  0  0\r\n 19 20  2  0  0  0  0\r\n 20 21  1  0  0  0  0\r\n 21 24  2  0  0  0  0\r\n 22 15  1  0  0  0  0\r\n 23 17  2  0  0  0  0\r\n 24 30  1  0  0  0  0\r\n 25 14  1  0  0  0  0\r\n 26 14  1  0  0  0  0\r\n 27 14  1  0  0  0  0\r\n 28  9  1  0  0  0  0\r\n 29 22  1  0  0  0  0\r\n 30 29  1  0  0  0  0\r\n 31 23  1  0  0  0  0\r\n 32 35  1  0  0  0  0\r\n 33 20  1  0  0  0  0\r\n 34 36  2  0  0  0  0\r\n 35 33  2  0  0  0  0\r\n 36 37  1  0  0  0  0\r\n 37 30  2  0  0  0  0\r\n 38 28  1  0  0  0  0\r\n 39 31  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 18 23  1  0  0  0  0\r\n 34 21  1  0  0  0  0\r\n 32 16  2  0  0  0  0\r\nM  END","cdbregno":"2","id":"ex 2(page 84)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"4.35","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"4.350000000000000e+000"},{"receptor":"Protease-activated receptor","assay":"Platelet aggregation assay","comments":"Inducer- gamma-Thrombin (~ 10 nM to 50 nM)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"4459","year":"2013","function":"Antagonist","organism":"Human (platelets)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"4.459000000000000e+003"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 35 40  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2042   -0.8125    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4750    0.4208    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9042    0.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.1792    0.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9125   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 10  1  0  0  0  0\r\n 15 18  1  0  0  0  0\r\n 16 12  1  0  0  0  0\r\n 17 14  2  0  0  0  0\r\n 18 23  2  0  0  0  0\r\n 19 15  2  0  0  0  0\r\n 20 15  1  0  0  0  0\r\n 21 14  1  0  0  0  0\r\n 22 16  2  0  0  0  0\r\n 23 26  1  0  0  0  0\r\n 24  9  1  0  0  0  0\r\n 25 21  1  0  0  0  0\r\n 26 25  1  0  0  0  0\r\n 27 22  1  0  0  0  0\r\n 28 29  1  0  0  0  0\r\n 29 20  2  0  0  0  0\r\n 30 19  1  0  0  0  0\r\n 31 32  2  0  0  0  0\r\n 32 33  1  0  0  0  0\r\n 33 26  2  0  0  0  0\r\n 34 24  1  0  0  0  0\r\n 35 27  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 17 22  1  0  0  0  0\r\n 31 18  1  0  0  0  0\r\n 28 30  2  0  0  0  0\r\nM  END","cdbregno":"3","id":"ex 3(page 89)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"3.08","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"3.080000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 38 44  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2417   -0.7292    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.5625    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7875   -0.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.3667    0.5958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   10.6042   -0.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7667    1.3083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   10.5917    1.3208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   11.0167    0.6083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 21  1  0  0  0  0\r\n 13 14  1  0  0  0  0\r\n 14  6  1  0  0  0  0\r\n 15 12  1  0  0  0  0\r\n 16 12  2  0  0  0  0\r\n 17 10  1  0  0  0  0\r\n 18 15  1  0  0  0  0\r\n 19 16  1  0  0  0  0\r\n 20 13  1  0  0  0  0\r\n 21 25  2  0  0  0  0\r\n 22 17  2  0  0  0  0\r\n 23 17  1  0  0  0  0\r\n 24 20  2  0  0  0  0\r\n 25 28  1  0  0  0  0\r\n 26  9  1  0  0  0  0\r\n 27 23  1  0  0  0  0\r\n 28 27  1  0  0  0  0\r\n 29 24  1  0  0  0  0\r\n 30 31  2  0  0  0  0\r\n 31 34  1  0  0  0  0\r\n 32 18  1  0  0  0  0\r\n 33 19  1  0  0  0  0\r\n 34 28  2  0  0  0  0\r\n 35 26  1  0  0  0  0\r\n 36 29  1  0  0  0  0\r\n 37 33  2  0  0  0  0\r\n 38 32  2  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 13  2  0  0  0  0\r\n 22 24  1  0  0  0  0\r\n 30 21  1  0  0  0  0\r\n 18 19  2  0  0  0  0\r\n 37 38  1  0  0  0  0\r\nM  END","cdbregno":"4","id":"ex 4(page 119)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"9.35","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"9.350000000000026e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 36 41  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7875   -0.1167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.3667    0.5958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.5625    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2417   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.9417    0.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.4167   -1.5417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 16  1  0  0  0  0\r\n 13 14  1  0  0  0  0\r\n 14  6  1  0  0  0  0\r\n 15 20  2  0  0  0  0\r\n 16 25  2  0  0  0  0\r\n 17 19  1  0  0  0  0\r\n 18 10  1  0  0  0  0\r\n 19 12  2  0  0  0  0\r\n 20 12  1  0  0  0  0\r\n 21 13  1  0  0  0  0\r\n 22 18  2  0  0  0  0\r\n 23 18  1  0  0  0  0\r\n 24 21  2  0  0  0  0\r\n 25 27  1  0  0  0  0\r\n 26  9  1  0  0  0  0\r\n 27 28  1  0  0  0  0\r\n 28 23  1  0  0  0  0\r\n 29 32  2  0  0  0  0\r\n 30 24  1  0  0  0  0\r\n 31 19  1  0  0  0  0\r\n 32 34  1  0  0  0  0\r\n 33 20  1  0  0  0  0\r\n 34 27  2  0  0  0  0\r\n 35 26  1  0  0  0  0\r\n 36 30  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 13  2  0  0  0  0\r\n 22 24  1  0  0  0  0\r\n 29 16  1  0  0  0  0\r\n 15 17  1  0  0  0  0\r\nM  END","cdbregno":"5","id":"ex 5(page 119)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"2.36","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"2.360000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 34 39  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.3667    0.5958    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.5625    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2417   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7875   -0.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 10  1  0  0  0  0\r\n 15 18  1  0  0  0  0\r\n 16 12  1  0  0  0  0\r\n 17 14  2  0  0  0  0\r\n 18 24  2  0  0  0  0\r\n 19 14  1  0  0  0  0\r\n 20 16  2  0  0  0  0\r\n 21 22  1  0  0  0  0\r\n 22 15  2  0  0  0  0\r\n 23 15  1  0  0  0  0\r\n 24 28  1  0  0  0  0\r\n 25 23  2  0  0  0  0\r\n 26  9  1  0  0  0  0\r\n 27 19  1  0  0  0  0\r\n 28 27  1  0  0  0  0\r\n 29 20  1  0  0  0  0\r\n 30 31  2  0  0  0  0\r\n 31 32  1  0  0  0  0\r\n 32 28  2  0  0  0  0\r\n 33 26  1  0  0  0  0\r\n 34 29  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 17 20  1  0  0  0  0\r\n 30 18  1  0  0  0  0\r\n 25 21  1  0  0  0  0\r\nM  END","cdbregno":"6","id":"ex 6(page 120)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"1.86","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"1.860000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 36 41  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.1792    0.8375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9042    0.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4750    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2042   -0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9125   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   10.6167    0.8500    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 10  1  0  0  0  0\r\n 15 12  1  0  0  0  0\r\n 16 23  2  0  0  0  0\r\n 17 14  2  0  0  0  0\r\n 18 24  2  0  0  0  0\r\n 19 27  2  0  0  0  0\r\n 20 14  1  0  0  0  0\r\n 21 15  2  0  0  0  0\r\n 22 18  1  0  0  0  0\r\n 23 22  1  0  0  0  0\r\n 24 30  1  0  0  0  0\r\n 25 22  2  0  0  0  0\r\n 26  9  1  0  0  0  0\r\n 27 25  1  0  0  0  0\r\n 28 20  1  0  0  0  0\r\n 29 19  1  0  0  0  0\r\n 30 28  1  0  0  0  0\r\n 31 21  1  0  0  0  0\r\n 32 33  2  0  0  0  0\r\n 33 34  1  0  0  0  0\r\n 34 30  2  0  0  0  0\r\n 35 26  1  0  0  0  0\r\n 36 31  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 17 21  1  0  0  0  0\r\n 32 18  1  0  0  0  0\r\n 19 16  1  0  0  0  0\r\nM  END","cdbregno":"7","id":"ex 7(page 120)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"1.29","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"1.290000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 38 43  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4750    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2042   -0.8125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.1792    0.8375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9042    0.4333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.9125   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   10.6167    0.8500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7542    0.8208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   11.3375    0.4458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 10  1  0  0  0  0\r\n 15 17  1  0  0  0  0\r\n 16 15  1  0  0  0  0\r\n 17 24  2  0  0  0  0\r\n 18 12  1  0  0  0  0\r\n 19 14  2  0  0  0  0\r\n 20 15  2  0  0  0  0\r\n 21 14  1  0  0  0  0\r\n 22 18  2  0  0  0  0\r\n 23 16  2  0  0  0  0\r\n 24 28  1  0  0  0  0\r\n 25  9  1  0  0  0  0\r\n 26 27  2  0  0  0  0\r\n 27 20  1  0  0  0  0\r\n 28 29  1  0  0  0  0\r\n 29 21  1  0  0  0  0\r\n 30 22  1  0  0  0  0\r\n 31 34  2  0  0  0  0\r\n 32 26  1  0  0  0  0\r\n 33 16  1  0  0  0  0\r\n 34 35  1  0  0  0  0\r\n 35 28  2  0  0  0  0\r\n 36 25  1  0  0  0  0\r\n 37 30  1  0  0  0  0\r\n 38 32  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 19 22  1  0  0  0  0\r\n 31 17  1  0  0  0  0\r\n 26 23  1  0  0  0  0\r\nM  END","cdbregno":"8","id":"ex 8(page 121)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"1.69","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"1.690000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 34 39  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.3667    0.5958    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.5625    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.2417   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7875   -0.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 10  1  0  0  0  0\r\n 15 18  1  0  0  0  0\r\n 16 12  1  0  0  0  0\r\n 17 14  2  0  0  0  0\r\n 18 25  2  0  0  0  0\r\n 19 22  1  0  0  0  0\r\n 20 14  1  0  0  0  0\r\n 21 16  2  0  0  0  0\r\n 22 15  2  0  0  0  0\r\n 23 15  1  0  0  0  0\r\n 24 23  2  0  0  0  0\r\n 25 28  1  0  0  0  0\r\n 26  9  1  0  0  0  0\r\n 27 20  1  0  0  0  0\r\n 28 27  1  0  0  0  0\r\n 29 21  1  0  0  0  0\r\n 30 31  2  0  0  0  0\r\n 31 32  1  0  0  0  0\r\n 32 28  2  0  0  0  0\r\n 33 26  1  0  0  0  0\r\n 34 29  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 17 21  1  0  0  0  0\r\n 30 18  1  0  0  0  0\r\n 19 24  1  0  0  0  0\r\nM  END","cdbregno":"9","id":"ex 9(page 121)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"1.26","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"1.260000000000000e+000"}]},{"molstructure":"\r\n  -ISIS-  02052418212D\r\n\r\n 35 40  0  0  0  0  0  0  0  0999 V2000\r\n    0.8417   -2.9042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.8375   -2.0792    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    2.1125   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6292   -3.1625    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0542   -3.1667    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0\r\n    2.9375   -2.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    0.0417   -1.8250    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    1.6250   -1.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -0.4375   -2.5000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -1.8250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.2125   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    3.4250   -3.1667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.4792   -0.4042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7875   -0.1167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -1.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    8.5625    0.4208    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.3667    0.5958    0.0000 N   0  0  3  0  0  0  0  0  0  0  0  0\r\n    9.2417   -0.7292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9292   -3.3250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7750   -0.8167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.0792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    4.9250   -0.8375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6500   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0542   -0.4167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.2625   -2.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    5.6375   -0.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -0.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3667   -3.3250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0\r\n    9.7000    1.3500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.7792   -1.6500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0667   -2.0667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    6.3542   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n   -1.6833   -1.7917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n    7.0792   -2.9125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0\r\n  2  1  1  0  0  0  0\r\n  3  4  1  0  0  0  0\r\n  4  1  2  0  0  0  0\r\n  5  1  1  0  0  0  0\r\n  6  3  1  0  0  0  0\r\n  7  2  1  0  0  0  0\r\n  8  2  1  0  0  0  0\r\n  9  5  1  0  0  0  0\r\n 10 11  1  0  0  0  0\r\n 11  6  2  0  0  0  0\r\n 12 13  1  0  0  0  0\r\n 13  6  1  0  0  0  0\r\n 14 21  1  0  0  0  0\r\n 15 19  2  0  0  0  0\r\n 16 10  1  0  0  0  0\r\n 17 14  2  0  0  0  0\r\n 18 17  1  0  0  0  0\r\n 19 14  1  0  0  0  0\r\n 20 12  1  0  0  0  0\r\n 21 25  2  0  0  0  0\r\n 22 16  2  0  0  0  0\r\n 23 16  1  0  0  0  0\r\n 24 20  2  0  0  0  0\r\n 25 28  1  0  0  0  0\r\n 26  9  1  0  0  0  0\r\n 27 23  1  0  0  0  0\r\n 28 27  1  0  0  0  0\r\n 29 24  1  0  0  0  0\r\n 30 18  1  0  0  0  0\r\n 31 32  2  0  0  0  0\r\n 32 33  1  0  0  0  0\r\n 33 28  2  0  0  0  0\r\n 34 26  1  0  0  0  0\r\n 35 29  1  0  0  0  0\r\n  7  9  2  0  0  0  0\r\n  3  8  2  0  0  0  0\r\n 10 12  2  0  0  0  0\r\n 22 24  1  0  0  0  0\r\n 31 21  1  0  0  0  0\r\n 18 15  1  0  0  0  0\r\nM  END","cdbregno":"10","id":"ex 10(page 122)","bioactivity":[{"receptor":"Protease-activated receptor","assay":"Ca2+ FLIPR assay","comments":"Inducer- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)\r\nStandard- H-Ala-Phe(4-F)-Pro-Gly-Trp-Leu-Val-Lys-Asn-Gly-NH2 (20 ul)","reference":"Priestley (Bristol-Myers Squibb Company), PCT, WO 13/163241 A1","source":"Patent","affinity":"3.55","year":"2013","function":"Antagonist","organism":"Human (HEK293-EBNA cells)","type":"PAR4","measure":"IC50","unit":"nM","therapeuticdata":"myocardial infarction, atherosclerosis, atrial fibrillation, acute coronary syndrome","uniprotid":"Q96RI0","unifiedvalue":"3.550000000000000e+000"}]}]